Cargando…
Natural killer cell immunotherapy to target stem-like tumor cells
Advances in cancer immunotherapy are leading to its increasing and successful application for the treatment of solid–tissue cancers. Despite the recent advances there are still significant barriers, in particular, evidence for significant tumor heterogeneity, both genetic and epigenetic that limit l...
Autores principales: | Grossenbacher, Steven K., Canter, Robert J., Murphy, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835831/ https://www.ncbi.nlm.nih.gov/pubmed/27096096 http://dx.doi.org/10.1186/s40425-016-0124-2 |
Ejemplares similares
-
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
por: Luna, Jesus I., et al.
Publicado: (2019) -
Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014) -
Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015) -
A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer
por: Canter, Robert J., et al.
Publicado: (2018) -
Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
por: Gingrich, Alicia A., et al.
Publicado: (2021)